Rami Al-Rohil, MBBS, has been promoted to Associate Professor of Pathology and Dermatology. Dr. Al-Rohil received his medical education at Jordan University of Science and Technology in 2008. After completing his internship and one year of Anatomic Pathology residency training in his medical school, he completed residency training in Anatomic and Clinical Pathology at Albany Medical Center in 2014. He also served as Chief Resident. Subsequently, Al-Rohil completed a Surgical Pathology fellowship followed by a Dermatopathology fellowship at the University of Texas MD Anderson Cancer Center. Prior to joining Duke University, he was appointed as an Assistant Professor of Pathology at Vanderbilt University from 2016 to 2018 where along with his clinical duties, he served as the Associate Program Director of the Surgical Pathology fellowship.
After joining Duke University in 2018, Al-Rohil has provided clinical services in the fields of dermatopathology, and soft tissue pathology, with his clinical and research focus geared mostly towards applying immunohistochemical and molecular testing to aid in accurately classifying melanocytic tumors and predicting their biologic potential; and the integration of molecular testing into anatomic pathology to diagnose various malignancies (including soft tissue tumors).
Al-Rohil received the Excellence in Teaching Anatomic Pathology Award at Vanderbilt University in 2017 and 2018, and received the Bernard F. Fetter Teaching Award in 2019 at Duke University. Al-Rohil has served as the Dermatopathology Fellowship Program Director since 2019, and as Clinical Research Unit Director for the Derma/Path Unit-Pathology division since 2020.
He has authored over 70 publications (manuscripts, book chapters, case reports, and abstracts) and has represented Duke Pathology in multiple national and international conferences, including the United States and Canadian Academy of Pathology (USCAP), American Society of Dermatopathology (ASDP), International Society of Dermatopathology (ISDP), and International Academy of Pathology (IAP). Most recently, Al-Rohil served as the lead investigator for the utility of Mass Spectrometry in diagnosing melanocytic tumors and the utility of proteomics in classifying cutaneous malignancies.